Nuvelo
Nuvelo
Nuvelo (pronounced: noo-veh-lo) is a biopharmaceutical company that specializes in the discovery, development, and commercialization of innovative drugs for the treatment of cardiovascular and cancer diseases.
Etymology
The term "Nuvelo" is a coined name and does not have a known etymology.
History
Nuvelo was established in 1996 in San Carlos, California. The company's primary focus is on the development of novel therapeutics for diseases with unmet medical needs. Nuvelo's research and development efforts are primarily focused on the areas of oncology and cardiovascular disease.
Products
Nuvelo's product portfolio includes drugs for the treatment of cancer, thrombosis, and inflammation. Some of the company's most notable products include Alfimeprase, a direct-acting fibrinolytic, and NU172, a direct thrombin inhibitor.
Related Terms
External links
- Medical encyclopedia article on Nuvelo
- Wikipedia's article - Nuvelo
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski